The largest database of trusted experimental protocols

28 protocols using il 10 pe

1

Flow Cytometric Identification of Lymphocyte Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the identification of CD4+ Th cell subsets and CD8+ Tc cells, we used cytoplasmic cytokine staining method. Briefly, whole blood were diluted to 1:1 with saline solution and incubated with phorbol-12-myristate 13-acetate (PMA) (25 ng/ml), ionomycin (1 μg/ml) and Golgi Stop brefeldin A (10 μg/ml) (all from Sigma Aldrich, St. Louis, Missouri, USA) for 5 h at 37°C in 5% CO2 milieu. The following monoclonal antibodies were used for cell surface staining: CD4-PE-Cy5 or CD8-PE-Cy5 (both from Beckman Coulter). The cells were then fixed and permeabilized with Intraprep™ permeabilization reagent (Beckman Coulter) according to the manufacturer’s instructions, and intracellular cytokines were stained with the combination of interferon (IFN)-γ-FITC, interleukin (IL)-4-PE, IL-10-PE (all from BD Biosciences) and IL-17-PE (R&D Systems, Minneapolis, MN, USA) monoclonal antibodies. Measurements were performed and data were analyzed on Coulter FC500 flow cytometer (Beckman Coulter) equipped with Kaluza 1.2a software. IgG1-FITC (BD Biosciences) and IgG1-PE (R&D Systems) isotype-matched antibodies were used during the identification. Cells were quantified as their percentage in the CD4+ or CD8+ lymphocyte population.
+ Open protocol
+ Expand
2

Cytokine Profiling of Activated Splenocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Splenocytes were obtained from mice and incubated at 37 °C for 6 h in 48-well plates coated with anti-CD3 and anti-CD28 antibodies (1 mg ml−1 each; eBioscience, San Diego, CA, USA). Cells were stained for 30 min at 4 °C with surface-specific antibodies (anti-CD3-allophycocyanin, anti-CD4-FITC and anti-CD8-PE–Cy5; BD Biosciences, Franklin Lakes, NJ, USA) and then fixed and permeablized through incubation for 10 min in 4% paraformaldehyde at room temperature. Cells were incubated for 30 min at room temperature with antibodies specific for candidate cytokines (anti-IFN-γ–PE, -IL-17–PE, -IL-4–PE and -IL-10-PE; BD Biosciences) and then analyzed on a FACSCalibur flow cytometer (BD Biosciences) using the CellQuest software (CellQuest, Largo, FL, USA).
+ Open protocol
+ Expand
3

In Vitro Differentiation and Analysis of TH17 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vitro differentiated and purified blood memory TH17 cells were restimulated during 3 h with PMA and ionomycin using the Cell Stimulation Cocktail (eBioscience) and then stained with Alexa647-IL26, Alexa488-IL17A, Alexa568-IL22 and Alexa750-IFNγ probes using PrimeFlow RNA Assay (eBioscience) according to the manufacturer’s protocol. In some experiments, intracellular cytokine staining of re-stimulated TH17 cells and blocked for secretion by Brefledin A after 1 h was performed using anti-human IL-9 PeCy7 (BioLegend, 1/20), IL-10 PE (BD Biosciences, 1/20), IL-13 BV421 (BioLegend, 1/20) and IL-21 PE (BioLegend, 1/20) antibodies before proceeding with the hybridization step of the Prime-Flow Assay. Cells were acquired on a FACS LSR II SORP (BD Biosciences) and analyzed with FlowJo_v10.7.1. A detailed gating strategy for this analysis is shown in Supplementary Fig. 8.
+ Open protocol
+ Expand
4

Multiparameter Analysis of Tonsillar Lymphocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tonsillar MNCs were treated with Brefeldin A (eBiosciences) for 4 h before harvesting cells in order to block cytokine secretion. MNCs were stained with fluorescence labeled anti-human CD4, followed by fixation and permeabilization and staining intracellularly with fluorescence labeled anti-human Foxp3, IL-17A, IFNγ, IL-10, RORγt, and Ki67 in different combinations. Stained cells were acquired on BD Celesta or BD Canto II and data was analyzed by Flowjo. Anti-human CD4-PECy7, IL-17A-Alexa Fluor 647, Foxp3-Alexa Fluor 488, IL-10-PE, and RORγt-PE FACS antibodies were from BD Biosciences. Other antibodies were purchased from BioLegend.
+ Open protocol
+ Expand
5

Comprehensive Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following antibodies were used: CD4-AlexaFluor 700, CXCR5-Biotin, ICOS-PECy7, Bcl-6-AlexaFluor 647, CD27-APCH7, CD45RA-PE, CD19-APC or V450, IgD-FITC, IL-21-AlexaFluor 647, IFN-γ-PECy7, IL-10-PE, Streptavidin-PE-TexasRed (BD Biosciences), CD38-PerCPeFluor710, IL-6-FITC, (Biolegend). Neutralizing antibodies specific for human IL-6 and IL-21R and isotype controls from R&D Systems.
+ Open protocol
+ Expand
6

Splenic Leukocyte Profiling by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
48 hours following the final behavioral test, spleens were harvested and a single cells suspension of splenocytes prepared for flow cytometry analysis as we have described previously23 ,26 (link). Splenocytes (106) were stained for markers of dendritic cell (DC) maturation and function—CD11c- PerCP-Cy5, MHCII-FITC, CD80-PE, and CD86-APC—or regulatory T cells—CD3-APC, CD4-FITC, CD25-PE-Cy7, and intracellular IL-10-PE (BD Pharmingen, San Diego, CA, USA; eBioscience, San Diego, CA, USA). Following surface staining, cells were fixed and permeabilized with BD Cytofix/Cytoperm before staining for intracellular markers. Data were acquired with FACSCanto (Becton Dickinson, Oakville, ON, Canada) and analysed using FlowJo (TreeStar, Ashland, OR, USA) with doublets and cell debris excluded by FSC and SSC gating. Gating strategies are shown in Fig. S1.
+ Open protocol
+ Expand
7

IL-10 Production in B-cells After CD40L Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs samples were thawed from liquid nitrogen on the same day as the staining and 3 × 106 PBMCs were stained with Live/Dead (Life Technologies Ltd, Paisley, UK), anti-CD20-AlexaFluor780 and CD86-PE (all eBioscience, Hatfield, UK) for 30 min/4 °C. 1 × 106 PBMCs from patient samples were rested overnight and the next day cells were cultured with 0.5 × 105 plate bound human-CD40L-transfected and non-transfected mouse L fibroblast cells (X-ray irradiated for 30 min 9,045 cGy) for 72 h. Intracellular IL-10-PE (BD) was measured in CD20+B-cells after CD40L activation.
+ Open protocol
+ Expand
8

Multiparametric Flow Cytometry of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were incubated with Fc Block (1 µg/106 cells; 2.4G2; BD Biosciences) for 15 min. Extracellular staining was performed for 30 min on ice using: CD4‐BV521 (RM4‐5; BioLegend, San Diego, CA, USA), CD45‐BV510 (30‐F11; BioLegend), CD3‐APC (17.A2, BioLegend), CD25‐PE‐Cy7 (PC61; BioLegend), CD8‐PerCPCy5.5 (53‐6.7; BioLegend), B220 (RA3‐6B2; BD Biosciences), CD11b‐PE‐Cy7 (M1/70; BioLegend), Ly6C‐PE (HK1.4; BioLegend), Gr1‐APC‐Cy7 (RB6‐8C5, BioLegend), IA/IE‐BV421 (M5/114.15.2, BioLegend), F4/80‐FITC (BM8, BioLegend), CD11c‐PerCPCy5.5 (N418, BioLegend).
After staining for extracellular proteins, cells were fixed in 4% PFA and permeabilised using 0.1% saponin buffer containing 0.1% bovine serum albumin. Intracellular cytokines were detected with IFNγ‐BV421 (XMG 1.2, BioLegend), IL‐10‐PE (54902, BD Bioscience), and IL‐17A‐AF647 (TC11‐18H10, BioLegend).
Flow cytometry was performed on a BD FACS Canto II (BD Biosciences) and analysed using FlowJo software version 10.6 (Treestar Inc., Ashland, OR, USA).
+ Open protocol
+ Expand
9

Flow Cytometry Immunophenotyping Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
For flow cytometry analyses cells were stained with antibodies to detect surface expressed CD4 (CD4 Alexa 488; CD4 APC; CD4 Percp [BD Biosciences]) and intracellular expressed RORγT, IL‐10, IL‐17A, and IFN‐γ (RORγt PE, IFN‐γ FITC, IL‐17A Percp, IL‐10 PE‐ BD biosciences). Staining was performed with Fix/Perm and Perm/Wash from BD Biosciences according to the manufacturer's protocols. To monitor cytokine expression by flow cytometry, cells were incubated with the corresponding stimuli and stimulated for 4 h in the presence of PMA (50 ng/mL), Ionomycin (500 ng/mL) and 1.5 μL/1 mio cells Golgi‐StopTM (BD Biosciences) before staining. Cells were analyzed using FACS Calibur from BD Bioscience and data analysis was performed with FlowJo software from Treestar (San Carlos).
+ Open protocol
+ Expand
10

Multiparameter Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
For surface staining, cells were stained with surface markers for 30
min on ice and washed twice with FACS buffer (PBS with 2% FBS and 2
mM EDTA buffer). After, cells were fixed and permeabilized with Fix/Perm
buffer (BD Biosciences) for 20 min on ice, washed twice with BD Perm/Wash,
and stained with the intracellular antibodies for 60 min on ice. For PoxP3
staining, cells were fixed and permeabilized with Fix/Perm Buffer
(eBiosciences, San Diego, CA, USA) for 60 min on ice, washed twice with
Perm/Wash buffer (eBiosciences) and stained with intracellular antibodies
for 60 min on ice. Subsequently, the cells were washed twice with the
respective Perm/Wash buffer and kept in 2% paraformaldehyde.
Antibodies used: PBS57-CD1d tet APC (kindly donated by NIH tetramer resource
facility), Vα24 FITC, and CD3 ECD were from Beckman Coulter
(Fullerton, CA), CD4 Qdot655, CD8 Qdot 605, and the viability marker AmCyan
were from Life Technologies (Carlsbad CA, USA), CD25 APC, CD38 PE, HLA-DR
PerCP, IFNγ V450, TNF Alexa700, IL-10 PE, and IL-4 PE-Cy7 were all
from BD bioscience. Data were acquired on a BD LSRFortessa instrument (BD
Biosciences) and analyzed using FlowJo Version 9.8.5 software (TreeStar,
Ashland, OR, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!